Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

HIV Drug ResistanceHIV Drug Resistance
           
Rollover images to visit our other forums!
  
  • Email Email
  • Glossary Glossary


meds
Sep 14, 2008

I am wondering if altripla and trizivir close to the same meds?

Response from Dr. Sherer

No. Although both are three drug combinations, they are NOT the same medications, and not even close.

Atripla is a three drug combination that contains efavirenz (EFV, Sustiva or Stocrin), emtricitabine (FTC or Emtriva), and tenofovir (TDF or Viread).

Trizivir is a three drug combination that contains abacavir (ABC, Ziagen), lamivudine (3TC or Epivir), and zidovudine (AZT, ZDV, or Retrovir).

The only components that are somewhat in common are FTC and 3TC, which are very similar in chemical structure, action, side effects, and resistance. However, there are also some differences, as FTC has a much longer half-life in the blood than 3TC.

Aripla is a preferred initial regimen for the treatment of HIV in the US HHS Guidelines. Trizivir is not recommended for use in initial treatment due to inferior virologic efficacy.


Previous
viral blip conundrum
Next
HIV Replication

  
  • Email Email
  • Glossary Glossary


 
 
Advertisement




Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement